Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Experimental adriamycin nephropathy. Fine structure, morphometry, glomerular polyanion, and cell membrane antigens.

Rossmann P, Matousovic K, Bohdanecká M.

J Pathol. 1993 Jan;169(1):99-108.

PMID:
8433220
2.

Experimental ablation nephropathy. Fine structure, morphometry, cell membrane epitopes, glomerular polyanion and effect of subsequent transplantation.

Rossmann P, Ríha I, Matousovic K, Bohdanecká M, Bukovský A.

Pathol Res Pract. 1990 Aug;186(4):491-506.

PMID:
1701048
3.

Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat.

Fries JW, Sandstrom DJ, Meyer TW, Rennke HG.

Lab Invest. 1989 Feb;60(2):205-18.

PMID:
2915515
4.

The development of focal segmental glomerulosclerosis in masugi nephritis is based on progressive podocyte damage.

Shirato I, Hosser H, Kimura K, Sakai T, Tomino Y, Kriz W.

Virchows Arch. 1996 Nov;429(4-5):255-73.

PMID:
8972762
5.

Puromycin aminonucleoside nephropathy: ultrastructure, glomerular polyanion, and cell surface markers.

Rossmann P, Bukovský A, Matousovic K, Holub M, Král J.

J Pathol. 1986 Apr;148(4):337-48.

PMID:
3517267
6.

Adriamycin-induced glomerulosclerosis in the rat.

Bertani T, Rocchi G, Sacchi G, Mecca G, Remuzzi G.

Am J Kidney Dis. 1986 Jan;7(1):12-9.

PMID:
3510531
7.

CCNU-adriamycin association induces earlier and more severe nephropathy in rats.

Raguenez-Viotte G, Lahoue M, Ducastelle T, Morin JP, Fillastre JP.

Arch Toxicol. 1988;61(4):282-91.

PMID:
3377683
8.

Albuminuria is not an aggravating factor in experimental focal glomerulosclerosis and hyalinosis.

Okuda S, Oochi N, Wakisaka M, Kanai H, Tamaki K, Nagase S, Onoyama K, Fujishima M.

J Lab Clin Med. 1992 Mar;119(3):245-53.

PMID:
1371800
9.

Adriamycin-induced chronic proteinuria: a structural and functional study.

O'Donnell MP, Michels L, Kasiske B, Raij L, Keane WF.

J Lab Clin Med. 1985 Jul;106(1):62-7.

PMID:
4009023
10.

Characterization of nephropathy induced by immunization with high molecular weight dextran.

Pasi A, Dendorfer U, Holthöfer H, Nelson PJ, Tazzari S, Armelloni S, Fornasieri A, D'Amico G, Schlöndorff D.

Nephrol Dial Transplant. 1997 Sep;12(9):1849-55.

PMID:
9306334
11.

Glomerular morphometry of adriamycin-induced focal and segmental glomerulosclerosis in the rat.

Güezmes A, Fernández F, Garijo F, Val-Bernal F.

Am J Nephrol. 1992;12(6):437-41.

PMID:
1292343
12.

Zonal distribution of glomerular collapse in renal allografts: possible role of vascular changes.

Nadasdy T, Allen C, Zand MS.

Hum Pathol. 2002 Apr;33(4):437-41.

PMID:
12055680
13.

Renoprotective effects of sirolimus in non-immune initiated focal segmental glomerulosclerosis.

Rangan GK, Coombes JD.

Nephrol Dial Transplant. 2007 Aug;22(8):2175-82. Epub 2007 Jun 5.

PMID:
17550925
14.

Tubulointerstitial disease in aging: evidence for underlying peritubular capillary damage, a potential role for renal ischemia.

Thomas SE, Anderson S, Gordon KL, Oyama TT, Shankland SJ, Johnson RJ.

J Am Soc Nephrol. 1998 Feb;9(2):231-42.

15.

Effects of captopril on morphologic changes in kidney of spontaneously hypertensive rats with adriamycin nephropathy.

Jovanovic D, Dimitrijevic J, Varagic J, Jovovic D, Starcevic A, Djukanovic L.

Ren Fail. 1998 May;20(3):451-8.

PMID:
9606733
16.
17.

Complement activation contributes to both glomerular and tubulointerstitial damage in adriamycin nephropathy in mice.

Turnberg D, Lewis M, Moss J, Xu Y, Botto M, Cook HT.

J Immunol. 2006 Sep 15;177(6):4094-102.

18.

C6 mediates chronic progression of tubulointerstitial damage in rats with remnant kidneys.

Nangaku M, Pippin J, Couser WG.

J Am Soc Nephrol. 2002 Apr;13(4):928-36.

19.

[Adriamycin-induced focal glomerular sclerosis: pathogenetic development and alteration of glomerular epithelial cells].

Ito K, Ger YC.

Nihon Jinzo Gakkai Shi. 1985 Aug;27(8):1113-22. Japanese. No abstract available.

PMID:
4087532
20.

Supplemental Content

Support Center